French study tracks Real-Life results of lung cancer drug
NCT ID NCT04500535
Summary
This study aimed to understand how the immunotherapy drug nivolumab works for people with advanced lung cancer in everyday medical practice. Researchers observed 535 patients in France who had already tried chemotherapy and whose doctors had decided to start nivolumab. The goal was to collect real-world information on how long the treatment worked, its side effects, and how it affected patients' quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Paris, 75248, France
Conditions
Explore the condition pages connected to this study.